Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/28/2003WO2002074783A3 Modified interferon beta with reduced immunogenicity
08/28/2003WO2002074048A8 P-glycoproteins and uses thereof
08/28/2003WO2002072823A3 Human g protein-coupled receptor
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002068469A3 Modified thrombopoietin with reduced immunogenicity
08/28/2003WO2002066660A3 Method for identifying herbicidally active substances
08/28/2003WO2002062369A3 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
08/28/2003WO2002055655A8 Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus
08/28/2003WO2002048310A3 Methods and compositions for diagnosing and treating rheumatoid arthritis
08/28/2003WO2002046443A3 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
08/28/2003WO2002045503A3 Transgenic mice containing targeted gene disruptions
08/28/2003WO2002043478A3 Transgenic transchromosomal rodents for making human antibodies
08/28/2003WO2002041921A3 Compositions for protection against bovine viral diseases
08/28/2003WO2002040661A3 TRANSGENIC MICE CONTAINING Kir2.3 POTASSIUM K+ CHANNEL GENE DISRUPTIONS
08/28/2003WO2002040539A3 Gpcr-like protein and nucleic acids encoding same
08/28/2003WO2002038174A3 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002036610A3 Haplotypes of the adora3 gene
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002033088A3 Human carboxypeptidase, scramblase, and protocadherin family members and uses thereof
08/28/2003WO2002030977A3 Egf motif protein, egfl6 materials and methods
08/28/2003WO2002029097A3 Methods relating to polymorphisms in the human gpr10 gene
08/28/2003WO2002027022A3 Methods for diagnosing and treating autosomal dominant optic atrophy
08/28/2003WO2002026818A3 Human nedd-1
08/28/2003WO2002026776A3 Peptide-based compounds
08/28/2003WO2002020756A3 Secretory molecules
08/28/2003WO2002020050A3 Eiav p26 deletion vaccine and diagnostic
08/28/2003WO2002012499A3 Haplotypes of the ntf3 gene
08/28/2003WO2002012498A3 Haplotypes of the isl1 gene
08/28/2003WO2002012342A3 Haplotypes of the edg4 gene
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002009642A3 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003WO2001096875A3 Hcv antigen/antibody combination assay
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003US20030163850 Polypeptides; transgenic plant; stress tolerance
08/28/2003US20030163848 Methods of commercial production and extraction of protein from seed
08/28/2003US20030163846 Process for the genetic modification of a plant
08/28/2003US20030163841 Better emergence characteristics and improved seedling growth under low-light environments
08/28/2003US20030163840 Genetic engineering; modulation Dna metabolism
08/28/2003US20030163839 Genetic engineering; polypeptide; transgenic plants
08/28/2003US20030163838 Adjusting concentration of cellulose synthase in plants; genetic engineering
08/28/2003US20030163837 Genetic engineering; transgenic plants
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162956 Leukocyte regulatory factors 1 and 2
08/28/2003US20030162955 Isolated mammalian membrane protein genes; related reagents
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162949 Stabilization; administering by injection
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162945 G- protein coupled receptor org10
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162943 Antibodies to polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor
08/28/2003US20030162942 Binding to ligand; adjustment of pH; elution
08/28/2003US20030162941 Graft polymer of polyester and polypeptide; prevent cyclization
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162740 Strategy for leukemia therapy
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162720 Therapeutic anti-HIV (IV9) compounds
08/28/2003US20030162718 Antigrowth agents; microbiocides, bactericides
08/28/2003US20030162715 Fertility; controlling cell differentiation
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162713 Genetic engineering; contorlling gene expression
08/28/2003US20030162712 Tek antagonists
08/28/2003US20030162710 Physiologically active polypeptide and DNA
08/28/2003US20030162707 Surgery; reducting inflammation, immunology response
08/28/2003US20030162703 Polypeptide antiulcer agents
08/28/2003US20030162702 Compositions and methods for altering cell migration
08/28/2003US20030162700 Central nervous system disorders; antiinflammatory agents; autoimmune disease; leukemia inhibitory factor
08/28/2003US20030162699 Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone
08/28/2003US20030162696 Modification of peptide; complexing; three-dimensional structure; hydrogen bonding
08/28/2003US20030162294 Genes involved in tolerance to environmental stress
08/28/2003US20030162291 Clk-2, cex-7 and coq-4 genes, and uses thereof
08/28/2003US20030162276 Retina specific; for inhibition of macular degeneration
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162273 Modulation of sulfate permease for photosynthetic hydrogen production
08/28/2003US20030162269 Strains additional genes chosen from dapA gene (dihydrodipicolinate synthase gene), lysC gene (aspartate kinase gene), lysE gene (lysine export carrier gene), dapB gene (dihydrodipicolinate reductase gene), are over-expressed
08/28/2003US20030162268 Retinoic acid (RA) regulated gene was cloned and expressed, its in vitro transcription and translation assayed and its chromosomal location determined; displays useful morphogenic/mitogenic properties
08/28/2003US20030162267 Culturing a corynebacterium glutamicum microorganism which overexpresses positive metabolic regulatory protein and underexpresses negative metabolic regulatory protein to increase the production of methionine
08/28/2003US20030162263 Specific peptide of 6 to 40 amino acids and is capable of giving rise to antibodies which inhibit superantigen activity associated with HERV-K18 (human endogenous retrovirus) localized in intron 1 of CD48 gene on chromosome 1
08/28/2003US20030162261 7-contiguous amino acids from interleukin p40, 7-contiguous amino acids from interleukin B30, and both
08/28/2003US20030162259 Kunitz domain polypeptide zkun10
08/28/2003US20030162258 Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
08/28/2003US20030162257 Probing a genomic library with all or a portion of a specific nucleic acid fragment, detecting a DNA clone that hybridizes with such nucleic acid fragment, determining the sequence of of DNA fragment containing the clone
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162255 Type-C lectins and methods of use
08/28/2003US20030162254 NaPi type IIb polypeptides and methods for making and using same
08/28/2003US20030162252 Isolating cDNAs encoding novel G protein-coupled receptor proteins derived from human spleen
08/28/2003US20030162251 Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM8
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/28/2003US20030162248 Having activities to inhibit Hemagglutination by Influenza Viruses; offers the specific peaks at the molecular weight of 1,000*1, 300 kDa when it is applied to 280 nm absorbance in Gel- Filtration Chromatography
08/28/2003US20030162247 32164 protein, a novel seven transmembrane protein
08/28/2003US20030162238 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
08/28/2003US20030162233 Method for purifying cancer-specific proliferating cell nuclear antigen
08/28/2003US20030162231 Alzheimer's disease; antiagglomerant of amyloid deposits
08/28/2003US20030162229 Immuno-interactive fragments of the alpha-C subunit of inhibin
08/28/2003US20030162227 Soluble, freely diffusible Sonic hedgehog protein
08/28/2003US20030162223 Detection of insecticide; determination, calibration of binding to protein
08/28/2003US20030162220 Detecting human infant kidney tumor; genetic engineered polypeptide
08/28/2003US20030162208 Cloned leptospira outer membrane protein
1 ... 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 ... 2916